Nature Publishing Group, publisher of Nature, and other science journals and reference works NATURE.COM NATURE NEWS NATUREJOBS NATUREEVENTS ABOUT NPG
Help Nature.com site index  
Leukemia
SEARCH     advanced search my account e-alerts subscribe register
Journal home
Advance online publication
Current issue
Archive
Press releases
For authors
For referees
Contact editorial office
About the journal
For librarians
Subscribe
Advertising
naturereprints
Contact NPG
Customer services
Site features
NPG Subject areas
Access material from all our publications in your subject area:
Biotechnology Biotechnology
Cancer Cancer
Chemistry Chemistry
Dentistry Dentistry
Development Development
Drug Discovery Drug Discovery
Earth Sciences Earth Sciences
Evolution & Ecology Evolution & Ecology
Genetics Genetics
Immunology Immunology
Materials Materials Science
Medical Research Medical Research
Microbiology Microbiology
Molecular Cell Biology Molecular Cell Biology
Neuroscience Neuroscience
Pharmacology Pharmacology
Physics Physics
Browse all publications
 
July 2002, Volume 16, Number 7, Pages 1205-1206
Table of contents    Previous  Abstract  Next   Full text  PDF
Spotlight on Signal Transduction Inhibitors: Basic Aspects and Therapeutic Implications
Spotlight Imatinib: a model for signal transduction inhibitors
A Hochhaus1, J A McCubrey2 and N Muller-Bérat Killmann3

1Guest Editor, Imatinib Spotlight

2Section Editor, Signal Transduction and Cytokines and Signal Transduction Inhibition

3Advisory Editor, Section Editor of 'Molecular Targets for Therapy'

Abstract

Leukemia (2002) 16, 1205-1206. doi:10.1038/sj.leu.2402575

July 2002, Volume 16, Number 7, Pages 1205-1206
Table of contents    Previous  Abstract  Next   Full text  PDF
Privacy Policy © 2002 Nature Publishing Group